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Case Report
Abstract
Narcolepsy is characterized by excessive sleepiness, cataplexy, hypnagogic hallucinations, and sleep paralysis during the rapid eye movement 
period of sleep. Herein, we present a boy aged eight years who was diagnosed as having narcolepsy and cataplexy about thirteen months after 
his first presentation. He was admitted with symptoms of daytime sleepiness. In the follow-up, cataplexy in the form of head dropping attacks 
developed seven months after the first admission. The patient was investigated for different prediagnoses and was eventually diagnosed as hav-
ing narcolepsy and cataplexy through polysomnography and multiple sleep latency tests thirteen months after the first presentation. He is being 
followed up and is under drug therapy; his symptoms have improved substantially. (Turk Pediatri Ars 2016; 51: 221-3)
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Introduction 
Narcolepsy is a rare disease caused by sleep disorder 
observed during the rapid eye movement (REM) phase 
of sleep, which is characterized by excessive sleepiness 
during daytime accompanied by sudden loss of muscle 
tonus, hallucinations while falling asleep, and sleep paral-
ysis (1). In children, the frequency has been estimated to 
be approximately 1/6 000 (2). It is thought to be related 
with disruption in hypocretin secretion as a result of auto-
immune damage in cells that secrete hypocretin (orexin) 
in the lateral hypothalamus. A hypocretin level of less than 
110 pg/mL in the cerebrospinal fluid (CSF) is diagnostic 
(3). In the diagnosis, multiple sleep latency test (MSLT) and 
CSF hypocretin measurement are needed in addition to 
appropriate clinical history. Presence of HLA DQB1 0602 
allele strongly supports the diagnosis (2, 3).
Case 
A boy aged 8 years presented with symptoms of exces-
sive sleepiness, imbalance, and falling asleep rapidly. In 
his history, it was learned that he had had headache, mal-
aise, blurred vision, and visual and auditory hallucinations 
while falling asleep for the last one week, and he had no 
symptoms of fever or vomiting, and no history of any re-
cent vaccination. There was no pathology in his personal 
and familial history. On systemic and neurologic exam-
ination, slow speaking, weak appearance, mild myosis in 
the pupils, and mild ataxia while walking in a straight line 
were observed. He was hospitalized with the prediagnosis 
of meningoencephalitis and acute disseminated encepha-
lomyelitis (ADEM) and protein, glucose, cell count, oligo-
clonal band, and herpes simplex type 1 polymerase chain 
reaction were studied in the CSF. Brain and spinal mag-
netic resonance imaging (MRI), electroencephalography 
(EEG), and serologic tests for Lyme, Salmonella and Bru-
cella were performed. These tests were found as normal 
and the patient was discharged after making an appoint-
ment with the division of pediatric psychiatry because of 
the presence of hallucinations and accompanying depres-
sive findings. Seven months after the first admission, the 
patient presented again after developing instant relaxation 
during laughing and head drops, in addition to his earli-
er symptoms. He was investigated with the prediagnosis 
of epilepsy, subacute sclerosing panencephalitis (SSPE) 
and autoimmune encephalitis. Autoimmune antibodies 
(Anti GAD, Anti Hu, Anti Yu, Anti NMDA, voltage-gated 
K channel antibody) and CSF measles IgG antibody were 
negative. A video EEG examination was found normal and 
an appointment for polysomnography was made with a 
prediagnosis of narcolepsy. The patient was followed up in 
an external center for five months and he presented again 
when his symptoms continued to worsen. On physical ex-
amination, it was found that his body weight increased by 
10 kg after the first presentation. Polysomnography and 
MSLT were performed 13 months after the first presenta-
tion. In the polysomnography, the total sleep time was 433 
minutes, the time to fall asleep was 0.4 minutes, and the 
time to enter REM sleep was 4 minutes (Table 1). In the 
multiple sleep latency test, the mean time to fall asleep 
was 1.5 minutes and all four tests revealed that sleep be-
gan with REM sleep, so called sleep-onset rapid eye move-
ment (SOREM) (Table 2). HLA DQB1*0602 allele, which 
was studied to support the diagnosis of narcolepsy was 
found positive. Modafanil and clomipramine treatment 
was initiated with a diagnosis of narcolepsy and cataplexy. 
In the follow-up visit performed one month later, it was 
learned that his symptoms had regressed markedly, sleep-
iness during the daytime was improved completely, cata-
plexy occurred rarely when he was extremely excited, he 
had started to attend school, and his academic success was 
good. On the follow-up examination, it was observed that 
his speech was more fluent and he lost weight. The patient 
is still being followed up in our clinic with a diagnosis of 
narcolepsy and cataplexy, and is receiving modafinil and 
clomipramine treatment without any problems. Written 
informed consent was obtained from the patient’s family.
Discussion 
Although narcolepsy is known to be a condition that oc-
curs in adults, it has been reported that the disease onset 
occurs in childhood and adolescence in most cases (4). In 
a retrospective study, it was found that the average time 
period between the onset of symptoms and the diagnosis 
was longer than 10 years in patients with narcolepsy (5). 
Patients with narcolepsy are usually initially investigated 
with the prediagnoses of epilepsy, encephalopathy, and 
psychiatric disease (5). Meningoencephalitis and acute 
disseminated encephalomyelitis were primarily con-
sidered in our patient because of sleepiness and slurred 
speech; investigations were performed and these prediag-
noses were excluded. 
Cataplexy is sudden loss of muscle tonus. It generally oc-
curs with emotional responses including laughing, excite-
ment, anger, and astonishment. It is observed in two thirds 
of patients with narcolepsy. Regional muscle involvement 
may be observed in these patients, as well as diffuse mus-
cle involvement. The most commonly involved muscles 
include the muscles of the chin, neck, arms, and legs. 
During a cataplexy episode, drooping of the jaw or entire 
head, loosening of the arms on both sides, and twisting or 
loosening of the legs may be observed. This status may be 
confused with atonic seizures or negative myoclonus (6). 
In our case, cataplexy was primarily interpreted as nega-
tive myoclonus and therefore, the patient was investigated 
in terms of SSPE and atonic seizure. These prediagnoses 
were excluded by way of long-term video EEG monitoring 
and measles-specific IgG in CSF. Patients with cataplexy 
have been followed up with different prediagnoses in the 
literature, similar to our patient (7). A pediatric patient with 
local cataplexy was followed up with chronic symptoms of 
jaw dropping, jaw surgery was planned but the patient was 
diagnosed as having cataplexy a short time before surgery. 
Another patient was followed up with a diagnosis of con-
version for many years (7).
The diagnosis of narcolepsy is supported by polysomnog-
raphy and later by MSLT. A dozing-off time shorter than 15 
minutes, frequently shorter than 5 minutes during the test 
and initiation of sleep during the REM period (achieve-
ment SOREM) are diagnostic (8). A diagnosis of narcolepsy 
was made in our patient with a mean dozing-off time of 
1.5 minutes in the MSLT test and because each drowsing 
period of four initiated in REM sleep. In addition, sleep 
apnea syndrome was excluded by specifying that the sleep 
apnea index was 2 in polysomnography. Hypocretin is a 
Table 2. Multiple sleep latency test results
Test Sleep latency SOREM
1 30 s Yes 
2 90 s Yes 
3 120 s Yes 
4 120 s Yes 
Mean  90 s 
SOREM: sleep onset rapid eye movement
Table 1. Polysomnography findings of the patient 
Total sleep time (min) 433
Sleep efficiency (%) 95.7
Sleep latency (min) 0.4
REM latency (min) 4
Stage 1 sleep rate (%)a 5.8
Stage 2 sleep rate (%)a 39.7
Stage 3 sleep rate (%)a 37.8
REM rate (%)a 16.7
Apnea hypopnea index (event/hour) 2
aPercentage by total sleep time 
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recently-defined neuropeptide and its levels in CSF have 
been found low in approximately 90% of patients with id-
iopathic narcolepsy and cataplexy (8). We could not study 
the CSF hypocretin level in our patient because we could 
not find any laboratory that studied hypocretin levels, 
which is substantially important in making the diagnosis. 
In our country, CSF hypocretin level is not a routine test 
and as far as we know, no laboratories are testing hypo-
cretin. 
In most patients with narcolepsy, the DQB1 0602 allele is 
found as positive (3). Therefore, a positive DQB1 0602 al-
lele in the presence of clinical findings is strong evidence 
for the diagnosis (3). In our case, the fact that the DQB1 
0602 allele was found as positive supported our diagnosis. 
Obesity frequently accompanies pediatric narcolepsy. This 
is thought to be related with accompanying hypothalam-
ic dysfunction, excessive sleepiness during the day, and 
reduced school attendance (3, 8). In the literature, it was 
reported that a patient who had been followed up because 
of hypothyroidism-related obesity was diagnosed as hav-
ing narcolepsy during the follow-up, and lost weight with 
appropriate treatment (7). In our patient, a 10 kg increase 
in body weight was found in a period of approximately 
one year, and normal body mass index was achieved after 
treatment. Therefore, body weight monitoring of children 
with narcolepsy during follow-up, as well as at the time 
of diagnosis is important in terms of the observation of 
treatment efficiency.
Although non-medical recommendations are present for 
the treatment of this disease (short naps during the day; 
exercise; diet recommendations; attention to sleep hy-
giene, which means to sleep at the same time each day and 
wakening at a certain time in the morning; achievement 
of better quality sleep by way of isolation of bedroom in 
terms of heat, noise, and light, and using appropriate beds; 
it has been recommended that medical treatment should 
be initiated immediately after the diagnosis is made and 
continued lifelong considering worse and painful out-
comes of the disease in children and adolescents  (6, 9). 
Modafinil and imipramine treatment was initiated in our 
patient after the diagnosis was made. Our patient is still 
being followed up with modafinil and imipramine treat-
ment and his symptoms have markedly decreased. 
In conclusion, narcolepsy is accompanied by learning dif-
ficulties and obesity because its symptoms are distribut-
ed in a wide spectrum, which may suggest many differ-
ent conditions, and affected children are often labeled as 
lazy. It is substantially difficult to make the diagnosis in 
patients with mild symptoms and patients are followed up 
with different prediagnoses in different outpatient clinics. 
The diagnosis is made years after the onset of symptoms 
in most cases. The fact that few pediatric cases have been 
reported in our country suggests that the diagnosis is be-
ing missed in this group of patients. Our patient was diag-
nosed 13 months after presentation and we presented this 
case in order to draw attention to narcolepsy and cataplexy 
in pediatric patients.
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